DATASHEET
Host:
Rabbit
Target Protein:
Semaphorin 3F
Immunogen Range:
201-300/785
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
6405
Swiss Prot:
Q13275
Source:
KLH conjugated synthetic peptide derived from human Sema3F
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
The semaphorins are a family of proteins that are involved in signaling. All the family members have a secretion signal, a 500-amino acid sema domain, and 16 conserved cysteine residues(Kolodkin et al., 1993 [PubMed 8269517]). Sequence comparisons have grouped the secreted semaphorins into 3 general classes, all of which also have an immunoglobulin domain. The semaphorin III family, consisting of human semaphorin III (SEMA3A; MIM 603961), chicken collapsin, and mouse semaphorins A, D, and E, all have a basic domain at the C terminus. Chicken collapsin contributes to path finding by axons during development by inhibiting extension of growth cones (Luo et al., 1993 [PubMed 8402908]) through an interaction with a collapsin response mediator protein of relative molecular mass 62K (CRMP62) (Goshima et al., 1995 [PubMed7637782]), a putative homolog of an axonal guidance associated UNC33 gene product (MIM 601168). SEMA3F is a secreted member of the semaphorin III family.
PRODUCT SPECIFIC PUBLICATIONS
- Hee Ra Park. et al. Antiseizure effects of Lilii Bulbus on pentylenetetrazol kindling-induced seizures in mice: Involvement of Reelin, Netrin-1, and semaphorin. BIOMED PHARMACOTHER. 2024 Apr;173:116385Read more>>
VALIDATION IMAGES
Mouse pituitary gland lysates probed with Semaphorin 3F Polyclonal Antibody, Unconjugated (bs-23306R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Mouse Brain lysates; Lane 2: Rat Brain lysates. Probed with Semaphorin 3F polyclonal Antibody, unconjugated (bs-23306R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.